Purchases and Sales Made in Q3 2022 in Cyclacel Pharmaceuticals, Inc. (CYCC)
This table provides information about the institutional ownership of Cyclacel Pharmaceuticals, Inc. (CYCC) during Q3 2022. The information is specifically focused on institutions that hold shares of Cyclacel Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Acadian Asset Management LLC
Boston, MA |
BUY
|
- |
301K+ 449.29% |
$370K - $6.58M
|
367K
$232K
|
|
Nov 14, 2022
Q3 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
- |
250KNew |
$308K - $5.48M
|
250K
$158K
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
105K+ 166.03% |
$129K - $2.29M
|
168K
$106K
|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
101K+ 19.58% |
$124K - $2.21M
|
615K
$388K
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
91K+ 87.13% |
$112K - $1.99M
|
195K
$123K
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
67.3KNew |
$82.8K - $1.47M
|
67.3K
$42.4K
|
|
Oct 18, 2022
Q3 2022
|
Mc Ilrath & Eck, LLC
|
BUY
|
- |
26.3KNew |
$32.4K - $577K
|
26.3K
$16.6K
|
|
Nov 01, 2022
Q3 2022
|
Kestra Advisory Services, LLC
|
BUY
|
- |
23KNew |
$28.3K - $504K
|
23K
$14.5K
|
|
Nov 14, 2022
Q3 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
12.8KNew |
$15.7K - $280K
|
12.8K
$8.06K
|
|
Nov 14, 2022
Q3 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
11.1KNew |
$13.7K - $243K
|
11.1K
$6.99K
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
10.7KNew |
$13.2K - $235K
|
10.7K
$6.75K
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
10.1KNew |
$12.4K - $221K
|
10.1K
$6.35K
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
10.1KNew |
$12.4K - $221K
|
10.1K
$6.35K
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
3.1K+ 18.13% |
$3.81K - $67.9K
|
20.2K
$12.7K
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
2K+ 13.37% |
$2.46K - $43.8K
|
17K
$10.7K
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
1.2KNew |
$1.48K - $26.3K
|
1.2K
$756
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
220+ 10.47% |
$271 - $4.82K
|
2.32K
$1.46K
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
10+ 1.78% |
$12.3 - $219
|
572
$360
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 04, 2022
Q3 2022
|
Simplex Trading, LLC
|
SELL
|
- |
-1.09K- 3.45% |
$1.34K - $23.8K
|
30.5K
$19.2K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-4.57K- 83.99% |
$5.62K - $100K
|
871
$549
|
|
Oct 25, 2022
Q3 2022
|
Raymond James Financial Services Advisors, Inc.
St. Petersburg, FL |
SELL
|
- |
-10K- 32.46% |
$12.3K - $219K
|
20.8K
$13.1K
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-156K- 47.61% |
$192K - $3.41M
|
171K
$108K
|